Clinical trials show tirzepatide produces approximately 2022% weight loss at the highest doses, compared to 1517% for dulaglutide in similar populations
3 Previously, mainstay treatment options for glycemic control included metformin, sulfonylureas (glimepiride, glipizide, and glyburide), thiazolidinediones (pioglitazone), and dipeptidyl peptidase-4 inhibitors (alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia)
Your body adapts to consistent medication levels through a process called receptor desensitization, and lifestyle drift often accompanies initial weight loss success
Many pharmacies accept expired medications for proper disposal
System Xc (SLC7A11 and SLC3A2) is critical for maintaining intracellular cysteine levels
In clinical trials, many participants lost between 5-10% of their body weight over a year